Parallel 6 Featured at ClinPulse Networking Event: “The Road to eConsent”

By October 22, 2015Blog, Clinical 6
clinical trial management platform

On Wednesday, November 18th, 2015 from 6 p.m. to 8:30 p.m., PRC Clinical, an Expert Clinical Trial Management CRO, will be organizing a panel and networking discussion event at Onyx Pharmaceuticals. A selected panel of industry experts will be discussing the topic “The Road to eConsent.” The evening will be featuring clinical trial executives, IRB leaders, and technology vendors including:

  • Mary Ann Battles – Head, Clinical Quality & Compliance, Early Development at Genentech.
  • Jim Gearhart – Board of Directors at Quorum Review IRB.
  • Brad Pruitt – Chief Medical Officer at Parallel 6.
  • Pierre Corin – Senior Global Project Manager at Genentech will moderate the panel.

Founded 35 years ago, Genentech is a leading biotechnology company that discovers, develops, manufactures, and commercializes medicines. Quorum Review is one of the largest IRBs providing ethics review to the human clinical trials industry. Parallel 6, an innovator in enterprise cloud and mobile technology, has developed Clinical 6™, which enables clinical trial stakeholders to digitally eQualify, eConsent, and engage with clinical trial participants via the web or a patient’s mobile device.

With 15-20% of clinical trials never enrolling a single patient, streamlining the subject enrollment process is one of the major challenges ahead for the clinical trial industry.

Also, in order to better enroll and engage patients, drug developers need to find the right method to better explain the objectives and processes at stake in a clinical study. eConsent, or electronic informed consent, is becoming an increasingly hot topic in the clinical trial industry. Earlier this year, the FDA issued a draft guidance for using informed consent in clinical investigations.

Curtis Head, CEO of PRC Clinical explains “Drug developers need to find the right medium to explain the objectives, scope, and processes of clinical studies to better enroll patients. We believe the eConsent is a cornerstone to streamline the study enrollment process and better engage subjects throughout the trial.”

The panel discussion will explore the possibilities, benefits, and challenges, of implementing an eConsent process for clinical studies.

  • How will eConsent impact the patient experience?
  • How will it improve and streamline the clinical trial process?
  • What are the different forms of eConsent already available and what lies ahead?
  • What are the current and upcoming national and international regulatory requirements to implement an eConsent process?

To follow the event in-person or to receive a recording of the panel, please register at

About Kamei Triebell